155 results on '"Xing, Yongna"'
Search Results
2. Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis
3. Disease mutations and phosphorylation alter the allosteric pathways involved in autoinhibition of protein phosphatase 2A.
4. Inherited duplications of PPP2R3B predispose to nevi and melanoma via a C21orf91-driven proliferative phenotype
5. B56δ long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan’s syndrome mutations
6. Structural hierarchy controlling dimerization and target DNA recognition in the AHR transcriptional complex
7. Development of Phenyl‐substituted Isoindolinone‐ and Benzimidazole‐type Cereblon Ligands for Targeted Protein Degradation.
8. Extended regulation interface coupled to the allosteric network and disease mutations in the PP2A-B56δ holoenzyme
9. Computational prediction and in vitro validation of VEGFR1 as a novel protein target for 2,3,7,8-tetrachlorodibenzo-p-dioxin
10. Purification of Target Proteins from Native Tissues: CCT Complex from Bovine Testes and PP2Ac from Porcine Brains
11. Author Correction: Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
12. Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
13. Coupling to short linear motifs creates versatile PME-1 activities in PP2A holoenzyme demethylation and inhibition
14. Author response: Coupling to short linear motifs creates versatile PME-1 activities in PP2A holoenzyme demethylation and inhibition
15. Coupling to short linear motifs creates versatile PME-1 activities in PP2A holoenzyme demethylation and inhibition
16. Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis
17. Roles of constitutive and signal-dependent protein phosphatase 2A docking motifs in burst attenuation of the cyclic AMP response element-binding protein
18. Cryo-EM and cellular dissection uncover versatile PME-1 activities in PP2A holoenzyme demethylation and inhibition
19. Structural Mechanism of Demethylation and Inactivation of Protein Phosphatase 2A
20. Generation of an Allelic Series at the Ahr Locus Using an Edited Recombinant Approach
21. Identification of the Ah-Receptor Structural Determinants for Ligand Preferences
22. Injecting skin fibroblasts into muscles to express human clotting factor IX cDNA
23. Inherited duplications ofPPP2R3Bpromote naevi and melanoma via a novelC21orf91-driven proliferative phenotype
24. The NMR‐based characterization of the FTY720‐SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET‐PP2A interaction
25. LOSS OF PI3K-DEPENDENCE FOR SURVIVAL OF MITOGEN-EXPANDED OLIGODENDROCYTE PROGENITOR CELLS IN VITRO.
26. Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)
27. Methylation-regulated decommissioning of multimeric PP2A complexes
28. PP2A-B' holoenzyme substrate recognition, regulation and role in cytokinesis
29. PP2A-B′ holoenzyme substrate recognition, regulation and role in cytokinesis
30. PP2A as a master regulator of the cell cycle
31. Centralspindlin assembly and 2 phosphorylations on MgcRacGAP by Polo-like kinase 1 initiate Ect2 binding in early cytokinesis
32. Structural Insights into the Tumor-Promoting Function of the MTDH-SND1 Complex
33. MTDH-SND1 Interaction Is Crucial for Expansion and Activity of Tumor-Initiating Cells in Diverse Oncogene- and Carcinogen-Induced Mammary Tumors
34. Mechanisms of the Scaffold Subunit in Facilitating Protein Phosphatase 2A Methylation
35. PR65A Phosphorylation Regulates PP2A Complex Signaling
36. Pr65A Phosphorylaion Regulates PP2A Complexation and Signaling
37. Partial Folding and Unique ATP Function in Protein Phosphatase 2A Latency and Activation
38. Structural basis of PP2A activation by PTPA, an ATP-dependent activation chaperone
39. Structure of the Ca2+-dependent PP2A heterotrimer and insights into Cdc6 dephosphorylation
40. Structural basis of protein phosphatase 2A stable latency
41. Structural basis of stable PP2A latency by α4‐protein
42. Structural insights into tight control of PP2A methylation and function by LCMT‐1
43. Structural basis of PP2A phosphatase activator reveals a unique chaperone function in PP2A activation
44. SU5416, a VEGF Receptor Inhibitor and Ligand of the AHR, Represents a New Alternative for Immunomodulation
45. The Structural Basis for Tight Control of PP2A Methylation and Function by LCMT-1
46. Methylation-Dependent Binding of the Epstein-Barr Virus BZLF1 Protein to Viral Promoters
47. Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV40
48. Structure of the Protein Phosphatase 2A Holoenzyme
49. Structure of Protein Phosphatase 2A Core Enzyme Bound to Tumor-Inducing Toxins
50. Structure and Mechanism of the Phosphotyrosyl Phosphatase Activator
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.